Cargando…
Deregulation of tumor suppressive ASXL1−PTEN/AKT axis in myeloid malignancies
Mutations of epigenetic regulators are pervasive in human tumors. ASXL1 is frequently mutated in myeloid malignancies. We previously found that ASXL1 forms together with BAP1 a complex that can deubiquitinylate mono-ubiquitinylated lysine 119 on histone H2A (H2AK119ub1), a Polycomb repressive mark....
Autores principales: | Cao, Lei, Xia, Xianyou, Kong, Yu, Jia, Fengqin, Yuan, Bo, Li, Rui, Li, Qian, Wang, Yuxin, Cui, Mingrui, Dai, Zhongye, Zheng, Huimin, Christensen, Jesper, Zhou, Yuan, Wu, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749738/ https://www.ncbi.nlm.nih.gov/pubmed/32236560 http://dx.doi.org/10.1093/jmcb/mjaa011 |
Ejemplares similares
-
Loss of Asxl2 leads to myeloid malignancies in mice
por: Li, Jianping, et al.
Publicado: (2017) -
ASXL1/2 mutations and myeloid malignancies
por: Medina, Edward A., et al.
Publicado: (2022) -
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012) -
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
por: Bera, Rabindranath, et al.
Publicado: (2019) -
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)